ITCs 451–455 and 457 were evaluated for their ability to inhibit the proliferation of the highly epidermal growth factor receptor (EGFR-TK) expressed in human epithelial cancer cells A431 and HaCaT cancer cells. This evidence concerns the gene EGFR and cancer.